STIM
Neuronetics, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$2.88
+5.88%Margins
Gross margin
49.1%
EBITDA margin
-13.7%
EBIT margin
-14.7%
Net margin
-19.6%
FCF margin
-6.5%
-170.5%
Return on equity
-23.1%
Return on assets
-21.9%
Return on invested capital
1.21x
Asset turnover
-$9.1M
Cash from operations
$0.25
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026